DNA mismatch repair status may influence anti-neoplastic effects of butyrate
DNA mismatch repair status may influence anti-neoplastic effects of butyrate
复制标题
DOI:
10.1042/bst0330728
复制
发表时间:
2005-08-01
影响因子:
3.9
通讯作者:
Mathers, JC
中科院分区:
文献类型:
--
作者:
Coxhead, JM;Williams, EA;Mathers, JC
HNPCC (hereditary non-polyposis colon cancer) is an autosomal-dominant disorder characterized by early-onset CRC (colorectal cancer). HNPCC is most often associated with mutations in the MMR (mismatch repair) genes hMLH1, hMSH2, hMSH6 or hPMS2. The mutator phenotype of a defective MMR system is MS1 (microsatellite instability), which also occurs in approx. 15-25% of sporadic CRC cases, where it is associated with the hypermethylation of the promoter region of hMLH1. Dietary factors, including excessive alcohol consumption, ingestion of red meat and low folate intake, may increase the risk of MS1 high turnout development. in contrast, aspirin may suppress MSI in MMR-deficient CRC cell lines. Butyrate, a short-chain-fatty-acid end product of carbohydrate fermentation in the colon, shares a number of anti-neoplastic properties with aspirin, including inhibiting proliferation and inducing apoptosis of CRC cells. Recent in vitro studies suggest that physiological concentrations of butyrate (0.5-2 mM) may have more potent antineoplastic effects in CRC cell lines deficient in MMR, but mechanisms for such a differential response remain to be established.